ATLASAbbott Laboratories (ABT) Q3 2026 earnings results
Abbott Laboratories (ABT) reported EPS of $1.42 against an analyst estimate of $1.43: in line with the estimate (-$0.01 (0.7%)). The quarter ended Sep 30, 2026; the company reported on Wednesday, October 21, 2026, before the open.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when Abbott Laboratories reports
Track ABT free Add Abbott Laboratories to a free ATLAS watchlist.
ABT Q3 2026 results at a glance
| EPS reported | $1.42 |
|---|---|
| EPS estimate | $1.43 |
| Surprise | In line · -$0.01 (-0.7%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 21, 2026, before the open |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Abbott Laboratories’s Q3 2026, a calendar-year company.
Abbott Laboratories EPS surprise history: last 5 quarters
Abbott Laboratories beat the EPS estimate in 2 of its last 5 reports, with an average surprise of +1.8%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 21, 2026 | $1.43 | $1.42 | -0.7% | In line | +0.1% |
| Jul 16, 2026 | $1.28 | $1.31 | +2.3% | Beat | +12.8% |
| Apr 16, 2026 | $1.15 | $1.15 | 0.0% | In line | -4.7% |
| Jan 22, 2026 | $1.49 | $1.50 | +0.7% | In line | -11.0% |
| Oct 21, 2025 | $2.10 | $2.24 | +6.7% | Beat | -1.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
ABT stock reaction to the report
ABT moved -1.89% in the first session that reflects the report (close of Oct 20, 2026 $102.45 to close of Oct 21, 2026 $100.51). Since the report: +7.53% (latest close $110.16 on Nov 2, 2026, against $102.45 before the reaction).
Next ABT earnings report
Abbott Laboratories has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the ABT earnings calendar.
ATLAS fair value and signal for ABT
| Last price | $110.16 (+3.7%) |
|---|---|
| ATLAS fair value | $73.93 (range $55.18–$117.07) · price is 49% above it |
| Chance of a higher close in 1 month | 52% (normal range $105.75–$115.48) |
These are model outputs from the same valuation and calibrated model as the Abbott Laboratories stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Abbott Laboratories Q3 2026 earnings: frequently asked questions
Did Abbott Laboratories beat earnings estimates for Q3 2026?
Abbott Laboratories reported EPS of $1.42 against an analyst estimate of $1.43: in line with the estimate (-$0.01 (0.7%)).
When did Abbott Laboratories report Q3 2026 results?
Abbott Laboratories reported on Wednesday, October 21, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does ABT beat EPS estimates?
In its last 5 reports with a recorded result, Abbott Laboratories beat the EPS estimate 2 times; the average surprise was +1.8%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer